Skip to main content
Premium Trial:

Request an Annual Quote

Investment Bank Upgrades Orchid BioSciences Stock; Shares Barely Budge

NEW YORK, July 29 (GenomeWeb News) - Caris & Company upgraded Orchid BioSciences' stock from 'above average' to 'buy' this morning.

 

News of the upgrade caused shares in Orchid to trade up 3.45 percent at $8.70 per share this afternoon.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more